Moody Aldrich Partners’s Pfizer PFE Stock Holding History

Moody Aldrich Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,136	Closed	-$348K	–	206
2024 Q4	$348K	Sell	13,136 -26	-0.2%	-$705	0.06%	148
2024 Q3	$381K	Sell	13,162 -44	-0.3%	-$1.28K	0.07%	145
2024 Q2	$370K	Sell	13,206 -8,798	-40%	-$242K	0.07%	144
2024 Q1	$611K	Buy	+22,004	New	+$611K	0.1%	133
2018 Q4	–	Sell	-4,897	Closed	-$205K	–	108
2018 Q3	$205K	Buy	+4,897	New	+$189K	0.06%	105

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moody Aldrich Partners's PFE Position: Q1 2025 in Review

Moody Aldrich Partners sold out of Pfizer (PFE) in Q1 2025, closing a stake of 13,136 shares — an estimated $348K sold.

Moody Aldrich Partners first reported a position in PFE in Q3 2018 and held it in 5 quarters. The position peaked at $611K in Q1 2024. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Moody Aldrich Partners reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Moody Aldrich Partners sold 13,136 Pfizer shares in Q1 2025, an estimated $348K.
Moody Aldrich Partners first reported a position in Pfizer in Q3 2018 and held it in 5 quarters.
Moody Aldrich Partners's Pfizer position peaked at $611K in Q1 2024.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Moody Aldrich Partners's 13F filing for Q1 2025, filed 29 Apr 2025.